We are live on ! Find out more
PFE icon

Pfizer
PFE

1,627 hedge funds and large institutions have $139B invested in Pfizer in 2013 Q2 according to their latest regulatory filings, with 1,627 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

73.6% more ownership

Funds ownership: 0% → 73.6% (+74%)

0% more call options, than puts

Call options by funds: $2.62B | Put options by funds: $2.62B

Holders
1,627
Holders Change
+1,627
Holders Change %
–
% of All Funds
52.91%
Holding in Top 10
290
Holding in Top 10 Change
+290
Holding in Top 10 Change %
% of All Funds
9.43%
New
1,627
Increased
–
Reduced
–
Closed
–
Calls
$2.62B
Puts
$2.62B
Net Calls
+$2.21M
Net Calls Change
+$2.21M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

PFE Hedge Fund Activity: Q2 2013 in Review

1,627 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q2 2013, worth a combined $139B.

Buyers outnumbered sellers: 1,627 funds opened new PFE positions and 0 closed out — a net gain of 1,627 holders — while 0 added to existing stakes and 0 trimmed.

  • 1,627 institutional investors held Pfizer (PFE) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $139B of Pfizer stock for Q2 2013.
  • 1,627 funds opened new Pfizer positions in Q2 2013 and 0 closed out, a net change of +1,627 holders.

Based on aggregated 13F filings for Q2 2013.